Akebia Therapeutics
AKBA
#7494
Rank
C$0.56 B
Marketcap
C$2.13
Share price
-3.14%
Change (1 day)
-26.65%
Change (1 year)

Market capitalization of Akebia Therapeutics (AKBA)

Market cap: C$0.56 Billion

As of December 2025 Akebia Therapeutics has a market cap of C$0.56 Billion. This makes Akebia Therapeutics the world's 7494th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Akebia Therapeutics from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025C$0.56 B-7.53%
2024C$0.61 B97.04%
2023C$0.30 B115.11%
2022C$0.14 B-71.42%
2021C$0.50 B-2.35%
2020C$0.51 B-48.62%
2019C$1.00 B14.06%
2018C$0.88 B-0.36%
2017C$0.88 B64.83%
2016C$0.53 B-2.44%
2015C$0.54 B99.71%
2014C$0.27 B

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of Akebia Therapeutics was reported to be:

C$0.56 Billion
by Nasdaq info icon info icon
C$0.56 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
C$245.40 B 43,368.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$350.33 B 61,952.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Johnson & Johnson
JNJ
C$672.11 B 118,948.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
C$1.59 B 183.22%๐Ÿ‡บ๐Ÿ‡ธ USA